ABSTRACT
P
hysicians are sometimes at a loss in predicting the potential outcomes of coiled aneurysms if minor recanalization is found during follow-up intervals. This is precisely why recanalization rates and related risk factors (based on initial angiographic results) have been addressed in most prior studies. Unfortunately, end points have thus far been measured as all recanalizations (major and minor), 1 major recanalization only, 2 or retreatment rates, 3 leaving a void with respect to the clinical course of aneurysms showing minor recanalization. In general, minor recanalization is not an indication for additional treatment, though progression to major recanalization may eventually call for further intervention. Lejeune et al 4 described a series of 21 coiled aneurysms subjected to additional surgical treatment for major recanalization (Raymond class 3). Lin et al 5 also reported that residual necks of 1-2 mm may expand to 4 -25 mm during a mean of 9 years. Accordingly, further study of the progression from minor-to-major recanalization is needed to devise proper treatment and management. For this study, we investigated treatment outcomes in aneurysms showing minor recanalization 6 months after coiling, assessing the clinical course, rate of progression to major recanalization, and related risk factors.
MATERIALS AND METHODS
A retrospective analysis was conducted, reviewing 1035 aneurysms in 898 patients who had undergone coil embolization between January 2008 and December 2010 at Seoul National University Hospital. Nonsaccular aneurysms (n ϭ 70) with fusiform shapes or resulting from dissection, trauma, or infection were excluded. In accord with institutional protocol, follow-up radio-logic examinations via 3D time-of-flight MR angiography, including source images, were conducted at 6, 12, 18, 24, and 36 months after coil embolization. Conventional angiography was advised if posttreatment MRA was not feasible or if major recanalization of an aneurysm was suspected by noninvasive diagnostics. As stipulated by the Raymond classification, recanalization at 6 months was defined as contrast filling the aneurysm neck (minor recanalization) or dome (major recanalization) at follow-up imaging. 2 The primary study end point was major recanalization during extended follow-up in coiled aneurysms showing only minor recanalization at 6 months. To categorize extended anatomic outcomes, we applied the Raymond scale as follows: progressive aneurysmal occlusion (no contrast filling within aneurysm), stable stationary state (contrast filling the neck of the aneurysm only, no change relative to the 6-month status), or major recanalization (saccular contrast filling, further recanalization relative to the 6-month status). Medical records were reviewed for multiple parameters, including sex, age, clinical presentation (unruptured intracranial aneurysm [UIA] or subarachnoid hemorrhage), aneurysmal status (initial or recanalized aneurysm), hypertension (HTN), diabetes mellitus (DM), smoking, and history of antiplatelet therapy. Angiographic variables assessed included the size of the aneurysm and its neck, location (anterior-versus-posterior circulation), 6 type of aneurysm (sidewall-versus-bifurcation), depth-to-neck ratio, packing density, stent deployment, and type of coil (hydrogelmodified coils [HydroSoft coils; MicroVention, Tustin, California] and polyglycolic acid/lactide copolymer-coated coils [Matrix coils; Stryker, Kalamazoo, Michigan]). According to the length of the bioactive coil used (relative to the total length of the coil inserted), aneurysms were grouped as bare (Յ50%) or bioactive (Ͼ50%) coils. 7 This study was approved by the institutional review boards.
Endovascular Procedure and Angiographic Follow-Up
Most of the endovascular procedures were conducted with the patient under general anesthesia, by using an Integris V (Philips Healthcare, Best, the Netherlands) scanner in each instance. Dual-agent antiplatelet therapy (loading doses of clopidogrel and aspirin [ie, 300 mg each] given 1 day before the procedure, with an additional morning dose of clopidogrel [75 mg] and aspirin [100 mg] on the day of the procedure) was administered if stent protection was anticipated in patients with unruptured aneurysms. 8 In poor responders to clopidogrel, signaled by VerifyNow P2Y12 assay (Accumetrics, San Diego, California), cilostazol was added. We prescribed single-agent (clopidogrel) therapy if stent placement was not planned, adding aspirin in poor responders. In patients presenting with SAH, antiplatelet medications were withheld. A bolus of heparin (3000 IU), given on placement of the femoral arterial sheath, was thereafter sustained by hourly doses (1000 IU); activated clotting time was monitored each hour. After the procedure, continuance of the dual antiplatelet therapy was advised for at least 3 months postoperatively, followed by singleagent maintenance for at least 1 year in patients with stent deployment. In the absence of a stent, antiplatelet therapy was selectively used for patients with prior antiplatelet medication histories, coil protrusion, and procedural thromboembolism. 
RESULTS

Characteristics of Coiled Aneurysms with Minor Recanalization at 6-Month Follow-Up
A total of 965 saccular aneurysms were treated by coil embolization between January 2008 and December 2010. After we excluded 66 aneurysms that lacked 6-month postembolization follow-up, including 16 patients in a vegetative state and 10 deaths, 899 aneurysms were initially eligible for the study. Another 34 aneurysms followed for 6 months only were also excluded. Of the remaining 865 aneurysms, 742 were completely occluded at the 6-month point and 58 demonstrated major recanalization. Ultimately, 65 aneurysms in 65 patients (48 women, 73.8%; mean age, 57.9 Ϯ 11.0 years) qualified for study during a mean extended follow-up of 24. Rates of HTN, smoking, and antiplatelet therapy were 60.0% (39/65), 13.8% (9/65), and 53.8% (35/65), respectively. Characteristics of aneurysms that qualified for the study are detailed in the On-line Table.
Morphologic Changes to Major Recanalization in Coiled Aneurysms with Minor Recanalization at 6 Months
Overall, 24 (36.9%) coiled aneurysms with minor recanalization at 6 months progressed to major recanalization during 112.5 aneurysm-years of follow-up, whereas none had become occluded. No instances of bleeding occurred during the follow-up. The chronology of change from minor-to-major recanalization was as follows: 14 (10/24) . Univariate analysis indicated an association between the presence of a stent and morphologic change to major recanalization (P ϭ .02). Other variables, such as SAH presentation (P ϭ .21), bifurcation type (P ϭ .74), second coiling for recanalized aneurysms (P ϭ .18), antiplatelet therapy (P ϭ .13), use of a balloon (P ϭ .41), residual sac as an immediate postembolization finding (P ϭ .47), and depth-to-neck ratio Ͼ1 (P ϭ .30), were unrelated to a change in recanalization status (Table 1) . Binary logistic regression analyses underscored the protective effect of stent placement on transformation to major recanalization (OR ϭ 0.22; 95% CI, 0.06 -0.87; P ϭ .03), whereas other variables, including antiplatelet therapy (OR ϭ 0.82; 95% CI, 0.25-2.68; P ϭ .75), posterior location (OR ϭ 0.24; 95% CI, 0.03-2.15; P ϭ .20), and second coiling for recanalized aneurysms (OR ϭ 0.96; 95% CI, 0.22-4.30; P ϭ .96), had no bearing on observed transformation to major recanalization ( Table 2) .
The overall annual rate of major recanalization in coiled aneurysms with minor recanalization at 6-month follow-up was 17.84% per aneurysm-year. The rate of change from minor-to-major recanalization was 7.79% per year in instances of stent deployment, as opposed to 16.67% without stent placement. With the Kaplan-Meier method, estimated cumulative survival at 30 months in the absence of major recanalization with and without stent deployment was 81.3% versus 47.4% (P ϭ .07).
DISCUSSION
Minor recanalization in aneurysms may remain stable with time or may progress to major recanalization. To our knowledge, accurate information on the likelihood of transforming from minor-to-major recanalization has been lacking. In our analyses, 36.9% of coiled aneurysms displaying minor recanalization at 6 months progressed to major recanalization during a follow-up of 112.5 aneurysm-years, for an overall annual rate of 17.84% per aneurysm-year.
Previous studies have reported variable rates (10.7%-33.6%) of overall recanalization in coiled aneurysms, with major recanalization ranging from 3.9% to 20.7%.
1,2 The propensity for recanalization in aneurysms is known to be a factor of presentation (SAH versus UIA), aneurysm size, and initial therapeutic results. 3 Ruptured (versus nonruptured) aneurysms are more likely to recanalize. 2, 9 Spontaneous clot lysis at rupture points or thrombus within the sac may contribute to a higher coil compaction in patients presenting with SAH, 9 which is the aim of interventionists. Sluzewski et al 10 reported that coiled aneurysms with volumes of Ͻ600 mm 3 did not undergo recanalization at packing densities of Ͼ24%. Morales et al 11 also showed that intra-aneurysmal hemodynamics, such as blood flow velocity and wall shear stress (WSS), may be reduced by increasing packing attenuation to near 30%. In our institution, we have tried to obtain high packing density and achieve anatomically complete occlusion regardless of presentation. In particular, complete occlusion is mandatory in ruptured aneurysms. As a result of the effort, the mean coil packing density was 32.1% Ϯ 9.2%, and the difference noted in subset packing densities was not significant according to presentation (UIA, 30.8 Ϯ 7.2%; SAH, 34.9 Ϯ 12.1%; P ϭ .15), except in 17 reembolized aneurysms (where estimating packing attenuation was not feasible).
Migration of a coil into the thrombus may also lead to major recanalization with time. 12 However, saccular thrombus is more easily detected in larger-sized aneurysms than in smaller ones. The aneurysm size did not differ significantly according to the presentation (SAH, 6.0 Ϯ 2.6 mm; UIA, 6.4 Ϯ 3.4 mm; P ϭ .66) in our cohort. Thus, we speculate that the relatively small-sized aneurysms and the higher packing densities of this cohort may be responsible for the lack of a significant correlation between SAH presentation and the rate of progression to major recanalization. In a study by Cognard et al, 9 a clinical correlation between aneurysm size and recanalization rate (2-3 mm, 8.7%; 4 -5 mm, 9.0%; 6 -8 mm, 22.0%) was found. The aneurysm size of Ͼ10 mm has been considered a risk factor for future recanalization. 13 Five cases (7.7%) with minor recanalization at 6 months after coiling were large aneurysms of Ͼ10 mm. Two (40.0%) of 5 large aneurysms and 22 (36.7%) of 60 small aneurysms (Ͻ10 mm) showed major recanalization, respectively (P ϭ 1.00). Therefore, we speculate that our results could be more appropriate for clinical evaluation of smallsized aneurysms with minor recanalization at 6-month follow-up imaging.
The initial therapeutic result is another reputed risk factor for future recanalization. Ries et al 3 showed that signs of a residual aneurysm immediately after endovascular treatment significantly increased the risk of recanalization, compared with completely occluded lesions (OR ϭ 3.96, P ϭ .006). However, projected recanalization rates of completely occluded coiled aneurysms and aneurysms with neck remnants after coiling were similar. In this study, initial angiographic results were stratified as successful occlusion (complete occlusion or residual neck) or residual sac. The higher rate of recanalization found in aneurysms showing minor recanalization 6 months after initial successful occlusion (versus residual sac) was not statistically significant (38.9% versus 27.3%, P ϭ .47). Recently, Ogilvy et al 16 devised a reliable recanalization stratification scale for projecting recanalization based on aneurysm-specific variables, initial occlusion status, and treatmentrelated factors. Aneurysm-specific variables, such as a size of Ͼ10 mm, ruptured state/presence of thrombus, and residual aneurysm (Raymond score of 3), are each awarded 2 points. As treatment-related factors, use of coils only, stent assistance, and flow diverter use earned 0, Ϫ1, and Ϫ2 points, respectively. If sums of individual scores were Ն5, the probability of retreatment was high (recanalization of Ͼ73.2%). Nevertheless, these results may not fully reflect the impact of risk factors, such as larger size, SAH presentation, and incomplete occlusion, on the progression from minor-to-major recanalization. Timing and duration of follow-up must be considered. Major recanalization largely emerged during the 12 months after embolization. In particular, 46.9% of all recanalizations (40% of which were major) were detected within the first 6 months of follow-up. 2 For our purposes, only
aneurysms showing minor recanalization 6 months after coiling were studied. Subjects were also monitored diligently during a mean extended follow-up of 24.8 Ϯ 8.2 months. Raymond et al 2 previously examined recanalization risk factors relative to the length of follow-up (Ͻ17 months versus 17-37 months versus Ͼ37 months). In patients followed for Ͻ17 months, the initial therapeutic result was the sole variable associated with recanalization; whereas in patients followed for 17-37 months, aneurysm and neck sizes and initial therapeutic results constituted risk factors. In patients followed for Ͼ37 months, aneurysm and neck sizes and SAH presentation were associated with recanalization. These results imply that recanalization developing longer term is dependent on inherent risk factors, with incomplete therapeutic occlusion primarily responsible in the short term. Hence, we thought that differing characteristics of subjects in our cohort, such as minor recanalization at 6 months, the relatively longer extended follow-up, and the stipulated study end point (minor to major recanalization), might explain the lack of significant correlation evident between risk factors established elsewhere and progression to major recanalization. The association between aneurysm location and recanalization remains controversial. Raymond et al 2 showed that recanalization rates at various sites (basilar bifurcation, 39.4%; MCA bifurcation, 32.1%; posterior communicating artery, 37.2%) did not differ substantially. On the other hand, Kwon et al 1 determined higher recanalization rates in coiled aneurysms of the posterior circulation and MCA due to technical difficulties. However, on the basis of study end point differences (all recanalization, major and minor) and selection bias (due to stent placement), the previous studies 1,2 failed to accurately depict the clinical correlation between aneurysm location and minor-to-major progressive recanalization. In our subjects, the rate of transformation to major recanalization was more pronounced in the anterior circulation (overall: 23/56, 41.1%; ICA: 5/16, 31.3%; anterior cerebral artery: 10/21, 47.6%; MCA: 2/9, 22.2%; posterior communicating artery: 6/10, 60%) than in the posterior circulation (1/9, 11.1%).
Rates of stent deployment differed by location, approaching statistical significance (anterior circulation: 14/56, 25.0% [ICA, 5; anterior cerebral artery, 5; MCA, 4; posterior communicating artery, 0]; posterior circulation: 5/9, 55.6%; P ϭ .08). These differing rates of stent deployment may explain the relatively higher proportion of major recanalization events in the anterior circulation. Hemodynamic forces are thought to figure prominently in aneurysms that recanalize. Luo et al 17 With respect to recanalized aneurysms, stent placement likewise reduced the major recanalization rate 6 months after retreatment (OR ϭ 0.16; P ϭ .01). 26 Still, the ability to prevent further recanalization (from minor to major) through stent deployment has yet to be clearly demonstrated. Our study indicates that stent placement does help prevent progression from minor-to-major recanalization (OR ϭ 0.22; P ϭ .03), and this benefit is conferred long term, past the 6-month follow-up point. Although some physicians find a 6-month determination of clinical course adequate in coiled aneurysms with minor recanalization, the durability of coiled aneurysms is a major concern due to relatively high recanalization rates (10.7%-33.6%).
1,2 Given that 46.9% of recanalization events take place in the first 6 months after embolization, 2 follow-up imaging is generally initiated within 6 months. However, the fate of aneurysms showing minor recanalization in the first follow-up images is often difficult to predict. Although treatment outcomes, including recanalization rates and related risk factors, have been well-described, potential transformation from minor-to-major recanalization may be a separate issue in terms of providing appropriate information and planning further follow-up. For this study, we have focused on the fate of aneurysms showing minor recanalization at 6-month follow-up, investigating a sizeable sampling (65 qualifying lesions) through strict patient monitoring. Consequently, the outcomes are likely valid. Nevertheless, there are concerns of possible selection bias, based on retrospective design and extent of stent deployment. Although, TOF MRA can be helpful in estimating the degree of recanalization, stent artifacts obscuring minor recanalization could occur. [27] [28] [29] [30] Moreover, the mean aneurysm size in our subjects was estimated at 6.3 Ϯ 3.2 mm. In Korea, coiled aneurysms Յ10 mm account for 89.3% of lesions in a national cohort of unruptured aneurysms. 1 As such, the fate of larger aneurysms (Ͼ10 mm) in this setting may differ.
CONCLUSIONS
In this study, a 36.9% rate of progression to major recanalization was determined in coiled aneurysms showing minor recanalization at 6 months. The cohort was followed for 112.5 aneurysmyears, yielding an annual transformation rate of 17.84% per aneurysm-year. The presence of a stent was the only variable analyzed that conferred a protective effect, preventing progression to major recanalization. The finding of minor recanalization at 6 months, especially in the absence of stent placement, is cause for continued monitoring of coiled aneurysms, due to a fair risk of late major recanalization.
